GE Healthcare and Ireland’s NIBRT will support the Jefferson Institute for Bioprocessing, set to open its doors next year. The site in Pennsylvania will train around 2,500 people in biomanufacturing operations per year. “There is high demand for trained professionals in the growing fields of biologics,†Debbie Goldberg, director of Public Relations at Jefferson (Philadelphia University + Thomas Jefferson University), told BioProcess Insider. As such, the education and training institute for bioprocessing has selected a site and will open its…
Wednesday, June 20, 2018 Daily Archives
BioSymphony No. 1: Oncobiologics Wins First CDMO Deal
Sonnet BioTherapeutics has contracted Oncobiologics to develop and manufacture four undisclosed biologic compounds. The Master Services Agreement (MSA) with Sonnet BioTherapeutics is the first to leverage Oncobiologics’ BioSymphony Platform, consisting of in-house monoclonal antibody (mAb) development and manufacturing capabilities. Lawrence Kenyon, Oncobiologics’ CFO, told BioProcess Insider the platform is used in a small biotech company setting, which results in a “more efficient and timely process for bringing mAbs forward.†He continued: “Our goal, and the purpose of the platform, is…